C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/25 (2006.01) A61K 38/20 (2006.01) A61K 39/395 (2006.01) C07K 14/54 (2006.01) C07K 14/545 (2006.01) C07K 16/18 (2006.01) C07K 16/24 (2006.01) C12P 21/08 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2081774
2081774 9117249 PCTABS00008 Medicaments that have prophylactic or therapeutic applications for the treatment of disease resulting from the production of cytokines, particularly IL-1, that effectively inhibit the biological activity of the cytokines wherein the medicaments are characterized by being proteinaceous materials lacking a signal sequence fo r which a cDNA sequence has been identified and sequenced.
Haskill John Stephen
Martin George
Ralph Peter
Borden Ladner Gervais Llp
Cetus Corporation
Chiron Corporation
The University Of North Carolina At Chapel Hill
University Of North Carolina At Chapel Hill
LandOfFree
Interleukin-1 antagonist and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-1 antagonist and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1 antagonist and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1719724